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1. Introduction
Neuroprotection is an approach to preserve neurons so that neurons cannot 
be hurt by different pathological factors in neurodegenerative diseases. It can be 
an approach before the onset of the disease so that neurons cannot be affected by 
any risk factors. It can also be an approach during the progression of the disease to 
prevent spreading of injury from one neuron to neighboring neurons. Therefore, 
neuroprotection can also be one approach as “disease-modifying agent” to delay and 
even stop progressive neurodegeneration.
The concept of neuroprotection has long been confined to intervene neurotrans-
mitter receptors via agonists and antagonists. A very well-known example is the 
neuroprotective effect of caffeine via adenosine receptor, because caffeine is an A2 
receptor antagonist. Caffeine can exert neuroprotection via adenosine A2 receptor 
to protect dopaminergic neurons in an experimental model of Parkinson’s disease 
(PD) by using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a toxin 
agent [1]. Therefore, drinking coffee has been considered to be neuroprotection. 
Apart from adenosine receptor on neurons, it is now known that microglial cells 
also express A2 receptor, and A2 receptor antagonist or caffeine can reduce activa-
tion of microglial cells [2]. Since caffeine or A2 receptor antagonists can protect 
neurons and minimize activation of microglial cells, research is still very active in 
this direction. Indeed, investigation of other neurotransmitter receptor antagonists, 
agonists, blockers, or even partial blockers is still a very active research area in 
neuroprotection.
While it is exciting to reveal differential neuroprotective effects via modulating 
receptors for different neurotransmitters, we should not restrict ourselves to this 
perspective only. In fact, a wider scope of neuroprotection has been evolved. The 
concept of neuroprotection can now be categorized into three groups: (A) pharma-
cological intervention, (B) non-pharmacological intervention, and (C) cellular and 
genetic approaches (Figure 1).
In group A neuroprotective approaches, pharmacological intervention includes 
modulation of neurotransmitter receptors (as introduced above), anti-oxidative 
stress, and anti-inflammatory responses [3]. These are classical pharmacologi-
cal approaches. These methods have been explored for decades and can be used 
for both neuroprotection and as disease-modifying agents. Their effects can be 
target-specific for one single protein (e.g., receptor for neurotransmitter or one 
type of cytokines) or pathway-specific (anti-oxidative responses using nuclear 
factor erythroid 2-related factor 2, Nrf2). Since single biological target may limit 
the beneficial effects and may not be able to intervene the complexity of the disease 
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progression, neuroprotective effects from herbal medicine or natural products 
receive increasing attention in scientific research because of their multiple effects 
on different biological targets [4–6]. For example, it has been shown that triterpe-
noids extracted from Prunella vulgaris has anti-inflammatory effects [7]. We have 
proved that polysaccharide part of Prunella vulgaris can modulate the immune 
responses of microglia and macrophages [8, 9]. Therefore, Prunella vulgaris exerts 
neuroprotection toward neurodegenerative diseases against neuroinflammation.
In group B neuroprotective approaches, non-pharmacological approaches 
receive increasing attention. Since it is quite difficult to ask a healthy adult or even 
elderly to constantly take medicine even though it is herbal, non-pharmacological 
approaches to earn neuroprotection are most welcome. Among these different 
methods, exercise is the best to prevent nearly all kinds of diseases. Exercise can be 
further divided into aerobic and resistance exercises, in which aerobic exercise is 
suitable for motor-healthy adults or elderly. However, there is a large population of 
elderly who have difficulty in their motor functions. Resistance exercise becomes an 
excellent tool for them. Both aerobic and resistance exercises can affect the metabo-
lisms of the body and induce trophic factors like myokines, released from muscles 
and liver [10, 11]. Since body metabolism is important, diet control is also impor-
tant to reduce any risk factors leading to the development of neurodegenerative 
diseases, such as diabetes, hyperlipidemia, or hypercholesterolemia. All of these 
risk factors are related to vascular components, which may further add on vascular 
dementia [12–14]. Apart from exercise, it is well-known that, maintaining social 
activity is essential to keep our brain healthy [15]. In addition, sleeping can promote 
clearing of pathological factors, such as β-amyloid (Aβ) peptide and phosphory-
lated tau protein [16, 17]. Also, it has been recently shown that learning second 
language or bilingualism can be neuroprotective [18]. Furthermore, increasing lines 
of evidence have shown that acupuncture can help adjusting the body metabolism 
and immunity [18, 19]. Therefore, acupuncture can also be considered to be one 
method in non-pharmacological approaches. One key point should be noticed that 
all these neuroprotective approaches are multiple targets. This may be why they are 
so effective in minimizing neurodegeneration to preserve neurons.
Neuroprotective approaches in group C are the new extension of multiple 
effects from trophic factors secreted by genetically engineered cells or viral vector. 
Alternatively, stimulating the proliferation and differentiation of endogenous stem 
Figure 1. 
A summary of different neuroprotective approaches.
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cells, application of induced pluripotent stem cells (iPSC), or mesenchymal stem 
cells are popular trends in scientific research to prevent neurodegeneration and 
neuronal loss [20–22].
Since there are several chapters about the effects of neurotransmitter receptors, 
we will focus on some neuroprotective approaches only, as this is an introductory 
chapter.
2. Neuroprotective effects of herbal medicine and natural products
This direction of neuroprotection is the most controversial approach among dif-
ferent pharmacological tools. This is because most of the herbal medicine or natural 
products have a wide array of effects. If we use traditional way of thinking to target 
a specific protein or signaling pathway, herbal medicine fails to do so. However, 
if we are aware of neurodegenerative diseases that are usually multifactorial, we 
can then accept that herbal medicine should be the direction to prevent neuronal 
loss and spreading of neurodegeneration. Our group has long been working on 
discovering herbal medicine as neuroprotective agents and investigating their 
underlying mechanisms. Since most of the herbal medicines are in decoction form, 
for oral consumption, the effective components in different herbs are not limited 
to one single chemical. The small molecules being extracted from one herb can also 
be found from other herbs. There are many laboratories investigating those small 
molecules and have Research and Development (R&D) to be commercial products. 
In contrast, big molecules such as polysaccharides have been an unexplored area. In 
fact, a large portion of components from herbs is polysaccharides. When we use hot 
water to prepare decoction, what we can easily absorb is polysaccharides. Therefore, 
we have investigated polysaccharides extracted from different herbs [23].
We have first found that polysaccharides from Nerium indicum exert neuroprotec-
tive effects against β-amyloid (Aβ) neurotoxicity cultured neurons [24, 25]. Then, we 
also found that neuroprotective effects of Verbena officinalis and Ganoderma lucidum 
[26, 27]. Having investigated different herbal medicine, we found that the polysac-
charides from Lycium barbarum (Wolfberry) are potent [28, 29]. Polysaccharides 
can be extracted in hot water or from alkaline condition and elicit neuroprotection 
[30]. It should be noted that not all polysaccharides, but only some sub-fractions 
provide neuroprotective effects. Apart from neurons in the brain, polysaccharides 
from wolfberry can also protect the retina against experimental glaucoma and stroke 
[31–33]. As harvesting and planting processes have good agricultural practice and the 
extraction can be done under stringent control of good manufacturing practice, we 
choose wolfberry as our long-term study. Wolfberry is indeed an anti-aging Chinese 
herbal medicine. We would like to understand the concept of “anti-aging.” Therefore, 
we have investigated its application in different aging-associated neurodegenerative 
diseases [34]. In fact, not all aging-associated neurodegenerative diseases can be 
attenuated by the polysaccharide fraction of Wolfberry. In Parkinson’s disease (PD), 
more potent antioxidants are required to provide neuroprotection.
In experimental PD using 6-hydroxydopamine (6-OHDA) as toxin agent, we 
employed oxyresveratrol, which is a natural product but a structural analog of 
resveratrol, and found that it can attenuate neurodegeneration [35, 36]. For this 
kind of neurodegenerative disease requiring high levels and high capacity of anti-
oxidant, another method is to employ pro-drug approach so that oxidant cleave the 
precursor and the product becomes potent antioxidant. Interestingly, polyphenol 
(-)-epigallocatechin-3-gallate (EGCG) from green tea falls in this category [37].
The advantages of using herbal medicine or natural products are to make use 
of their multiple effects. In neurodegenerative diseases, a wide array of stress 
responses is stimulated because of free radicals or accumulation of misfolded or 
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badly folded proteins. Most of the herbal medicine and natural products attenuate 
many stress kinases. They may not be a good candidate to clear accumulation of bad 
proteins; however, they can inhibit the cascades of stress responses (e.g., activa-
tion of c-Jun-N-terminal kinase, JNK; endoplasmic reticulum stress pathways), 
which usually lead to neuronal apoptosis. Some of the herbal medicine or natural 
products can even strengthen the survival signaling pathways such as mTOR or Akt 
pathways.
In addition to their direct effects on neurons, there are many herbal medicine or 
natural products that can modulate body immune responses. For example, polysac-
charides fraction from Prunella vulgaris L. can modulate innate immune responses 
of macrophages [8, 9]. It has been increasingly aware that activation of body 
(systemic) immune responses are the origin of our sickness responses leading to low 
appetites and even fever [38]. Long-term effects of systemic immune responses can 
even result in psychological depression or acute delirium [39]. Experimentally, we 
have shown that infection in the body or immune responses triggered by surgery 
(laparotomy) can modulate cognitive functions because of stimulation of neu-
roimmune responses [40, 41]. Therefore, modulation of body immunity can be a 
powerful method to minimize neuroimmune responses and then reduce cognitive 
dysfunctions.
3. Aerobic and resistance exercises
As emphasized above, the advantages of herbal medicine and natural products 
are their multiples and wide array effects. Similarly, exercise is another method to 
achieve this goal. Exercise can stimulate production of different trophic/growth fac-
tors, e.g., vascular endothelial growth factor (VEGF), brain-derived neurotrophic 
factor (BDNF), insulin-like growth factor-1 (IGF-1), peroxisome proliferator-
activated receptor gamma coactivator-1α (PGC-1α)/neuronal fibronectin type 
III domain-containing protein 5 (FNDC5). Some trophic factors can be secreted 
by muscles or liver, which is collectively called myokines. It has been shown that 
muscle cells can produce PGC-1α, irisin, cathepsin B, myostatin (growth differen-
tiation factor 8), fibroblast growth factor 21 (FGF-21), IL-6, IL-15, myonectin, and 
SPARC (osteonectin) as novel brain-beneficial myokines [10, 42]. Some of them, 
such as FGF21, can also be secreted by the liver or even in the brain upon exercise 
[43]. They all can affect muscle, liver, adipose tissues, and brain cells, leading to 
preservation of cognitive functions, modulating the lipid metabolism, and immune 
responses [44]. This kind of myokine can pass through the blood-brain barrier.
For motor-healthy subject, aerobic exercise is beneficial to majority of people. 
As discussed above, myokines can be induced so that they provide neuroprotective 
effects to the brain and attenuate any systemic immune responses. While aerobic 
exercise is known to be good, a great number of elderly and demented patients 
could not enjoy the benefit of aerobic exercise. Those patients may have prior knee 
replacement or fall down hurting the legs. They may be lying down on the bed. No 
matter how we advocate the beneficial effects of aerobic exercise, this will not be 
beneficial to this group of patients. Does it mean that they will not have any benefi-
cial effects of exercise? This question leads us to investigate the beneficial effects of 
resistance exercise.
In a systematic review, aerobic exercise shows beneficial effects on cognitive 
functions and executive functions, which is better than that from resistance exer-
cise [45]. Furthermore, aerobic exercise seems to elicit strong anti-inflammatory 
effect than that of resistance exercise [46]. However, resistance exercise seems to 
particularly increase the volume of hippocampus [47]. A study in laboratory animal 
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has shown that aerobic exercise can markedly increase BDNF; whereas, resistance 
exercise can significantly increase IGF-1 [48]. Although resistance exercise may 
have some limitations, this is still a good choice for those elderly and dementia 
patients to have this form of exercise. IGF-1 can still elicit multiple functions in the 
brain to preserve neurons.
4. Concluding remarks
Since this is an introductory chapter, we do not intend to discuss every single 
method of neuroprotection in detail. We should keep in mind that neurodegenera-
tive diseases are multiple-hit processes. Therefore, no single biological target can 
afford all neuroprotective needs. Approaches in using herbal medicine and natural 
products remind us that multiple biological targets may be the way to exert effec-
tive neuroprotection. Therefore, any non-pharmacological approaches including 
exercise and even the new stem cell approaches exert multiple effects. This can be 
the way for our effective neuroprotective strategies.
6Neuroprotection
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